Insights into Company

Simplex Infrastructures Limited

πŸ“ Kolkata, West Bengal, India Active NSE SIMPLEXINF CIN L45209WB1924PLC004969 Real Estate & Construction
Search companies

Key Metrics of Simplex Infrastructures Limited

Revenueβ‚Ή670 Crβ–Ό 8.4% YoYFY 2025-26
EBITDAβ‚Ή90.8 Crβ–² 2.2% YoY
Net profitβ‚Ή37.7 Crβ–² 291.7% YoY
Net worthβ‚Ή956 Crβ–² 88.2% YoY
Competitors10identified

About Simplex Infrastructures Limited

Sectors

Real Estate & ConstructionReal Estate & Infrastructure

Company details

Registered office
Simplex House 27 Shakespeare Sarani, Kolkata, In-wb, 700017
Listed
NSE: SIMPLEXINF Β· β‚Ή252.11

Operational Areas of Simplex Infrastructures Limited

Real Estate & Constructionβ€ΊReal Estate & Infrastructure

Company summary

Entity details

CINL45209WB1924PLC004969
LEI code335800ZWUFKFGY42ID70
State codeWB
PIN code700017
Current legal nameSIMPLEX INFRASTRUCTURES LIMITED
Classificationβ€”
Listing statusListed (NSE: SIMPLEXINF)
Registration no.004969
Company ageβ€”
PANβ€”
CountryIndia
CityKolkata
StateWest Bengal
Current statusActive
Date of incorporationβ€”
Registrar of companiesβ€”
Authorised capitalβ€”
Paid-up capitalβ€”
Employee countβ€”

Compliance

Last AGM dateβ€”
Last balance sheetβ€”
Next filing dueAOC-4 for FY 2025-26 Β· 30 Oct 2026

Industry classification

NIC code45209
Description of main activityConstruction
Description of business activityConstruction
SectorReal Estate & Construction Β· Real Estate & Infrastructure
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date Β· 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date Β· 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE Β· 14 Nov 2025 CARE D Non-cooperating
Change in last 12 monthsNo change
Change since first rating on recordβ–Ό 13 notchessince Jun 2019
Rating actions100 up Β· 0 down

WatchIssuer not cooperating with CARE (rating based on limited information)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
14 Nov 2025CARENon-cooperating Dβ€”β€”β‚Ή11,070 Cr View
19 Nov 2024CARENon-cooperating Dβ€”β€”β‚Ή11,070 Cr View
23 Nov 2023CARENon-cooperating Dβ€”β€”β‚Ή11,070 Cr View
28 Nov 2022CARENon-cooperating Dβ€”β€”β‚Ή22,141 Cr View
02 Dec 2021CARENon-cooperating Dβ€”β€”β‚Ή495 Cr View
10 Dec 2020CAREReaffirmed Dβ€”β€”β‚Ή10,575 Cr View
11 Dec 2019CARERevised (from BB+) DA4+Negativeβ‚Ή10,500 Cr View
25 Nov 2019CARERevised (from BBB) BB+A3+Negativeβ‚Ή10,500 Cr View
14 Aug 2019CARERevised (from A) BBBA2+Negativeβ‚Ή10,500 Cr View
10 Jun 2019CARERevised (from A) A-A2+Negativeβ‚Ή10,524 Cr View

Credit strengths (CARE, Nov 2023)

β€”

Credit challenges

βˆ’ Delay in servicing of debt obligations

There are on-going delays in debt servicing obligation of the company. The slowdown in recoveries from clients, delays in approvals of bills from government clients resulted in stretched liquidity position of the company, thus resulting in delays.

Could lead to an upgrade

ο‚· Regularization of debt servicing for a continuous period of 3 months. ο‚· Company earning sufficient cash accruals so as to meet its debt repayment obligations.

Agency-reported financials (CARE, 14 Nov 2025)

MetricMarch 31, 2024March 31, 2025Q1FY26
Total operating incomeβ‚Ή1,002 Crβ‚Ή724 Crβ‚Ή154 Cr
PBILDTβ‚Ή20.98 Crβ‚Ή14.59 Crβ‚Ή15.63 Cr
PATβ‚Ή-71.89 Crβ‚Ή9.63 Crβ‚Ή3.52 Cr
Overall gearing (times)32.96Γ—4.29Γ—β€”
Interest coverage (times)0.26Γ—0.94Γ—β€”
Revenue growth (YoY)β€”βˆ’27.7%β€”
EBITDA margin2.1%2.0%10.2%
Implied interest cost (EBITDA Γ· coverage)β‚Ή80.69 Crβ‚Ή15.52 Crβ€”
PAT marginβˆ’7.2%1.3%2.3%

Borrowings & rated debt

Rated borrowing limits (latest)β‚Ή11,070 Cr
Peak rated limitsβ‚Ή22,141 CrNov 2022 Β· CARE
Limits raised0 times1 new facility rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
crore) ISSUER NOT continues to remain under Long Term Bank FacilitiesWorking capital & bank linesβ€”β‚Ή2,675 Crβ€” DOtherCARE
Long Term Short Term Bank ISSUER continues to remain under Facilities NOTWorking capital & bank linesβ€”β‚Ή7,900 Crβ€” DNon-cooperatingCARE
ISSUER NOT continues to remain under Non-Convertible DebenturesDebentures & bondsβ€”β‚Ή170 Crβ€” DOtherCARE
ISSUER NOT continues to remain under Non-Convertible DebenturesDebentures & bondsβ€”β‚Ή200 Crβ€” DNon-cooperatingCARE
ISSUER NOT continues to remain under Non-Convertible DebenturesDebentures & bondsβ€”β‚Ή75.0 Crβ€” DNon-cooperatingCARE
ISSUER NOT continues to remain under Non-Convertible DebenturesDebentures & bondsβ€”β‚Ή50.0 Crβ€” DNon-cooperatingCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE059B07013Jun Jun ISSUER NOTDebentures & bondsβ€” β€”β€” β€”β€” Not stated
INE059B07021Dec Dec ISSUER NOTDebentures & bonds12.75% β€”β€” β€”β€” Not stated
INE059B07039Dec Dec ISSUER NOTDebentures & bonds12.75% β€”β€” β€”β€” Not stated
INE059B07047Feb Feb ISSUER NOTDebentures & bonds14.25% β€”β€” β€”β€” Not stated
INE059B07120Jan Jan ISSUER NOTDebentures & bonds15.65% β€”β€” β€”β€” Not stated
INE059B07138Jul Jun ISSUER NOTDebentures & bonds15.05% β€”β€” β€”β€” Not stated
INE059B07146Jun Jun ISSUER NOTDebentures & bonds15.05% β€”β€” β€”β€” Not stated
INE059B07088Mar Mar ISSUER NOTDebentures & bonds14.50% β€”β€” β€”β€” Not stated
INE059B07070Mar Mar ISSUER NOTDebentures & bonds14.50% β€”β€” β€”β€” Not stated
INE059B07062Mar Mar ISSUER NOTDebentures & bonds14.50% β€”β€” β€”β€” Not stated
INE059B07054Dec Dec ISSUER NOTDebentures & bonds14.50% β€”β€” β€”β€” Not stated
INE059B07104Jul Jul ISSUER NOTDebentures & bonds13.15% β€”β€” β€”β€” Not stated
INE059B07096Jul Jul ISSUER NOTDebentures & bonds13.15% β€”β€” β€”β€” Not stated

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LCβ‚Ή7,900 CrCARE D / CARE D; ISSUER NOT COOPERATING*
Cash Creditβ‚Ή2,600 CrCARE D; ISSUER NOT COOPERATING*
Commercial Paper (Carved out)β€”Withdrawn
CP/STDβ€”Withdrawn
Long Termβ€”Withdrawn
Non Convertible Debenturesβ‚Ή495 CrCARE D; ISSUER NOT COOPERATING*
Term Loanβ‚Ή75.4 CrCARE D; ISSUER NOT COOPERATING*

Lenders

Fund-based - LTCash CreditAllahabad Bank
Fund-based - LTCash CreditAndhra Bank
Fund-based - LTCash CreditAxis Bank Ltd.
Fund-based - LTCash CreditBank of Baroda
Fund-based - LTCash CreditBank of India
Fund-based - LTCash CreditBank of Maharashtra
Fund-based - LTCash CreditCanara Bank
Fund-based - LTCash CreditCentral Bank of India
Fund-based - LTCash CreditDCB Bank Ltd.
Fund-based - LTCash CreditDena Bank
Fund-based - LTCash CreditHDFC Bank Ltd.
Fund-based - LTCash CreditICICI Bank Ltd.
Fund-based - LTCash CreditIDBI Bank Ltd.
Fund-based - LTCash CreditIndian Bank
Fund-based - LTCash CreditInduslnd Bank Ltd.
Fund-based - LTCash CreditKarnataka Bank Ltd.
Fund-based - LTCash CreditKarur Vysya Bank Ltd.
Fund-based - LTCash CreditLakshmi Villas Bank
Fund-based - LTCash CreditOriental Bank of Commerce
Fund-based - LTCash CreditProposed
Fund-based - LTCash CreditPunjab National Bank
Fund-based - LTCash CreditRBL Bank Limited
Fund-based - LTCash CreditStandard Chartered Bank
Fund-based - LTCash CreditState Bank of India
Fund-based - LTCash CreditSyndicate Bank
Fund-based - LTCash CreditUCO Bank
Fund-based - LTCash CreditUnion Bank of India
Fund-based - LTCash CreditUnited Bank of India
Fund-based - LTCash CreditYes Bank Ltd.
Fund-based - LTTerm LoanInduslnd Bank Ltd.
Fund-based - LTTerm LoanProposed
Non-fund-based - LT/ STBG/LCAllahabad Bank
Non-fund-based - LT/ STBG/LCAxis Bank Ltd.
Non-fund-based - LT/ STBG/LCBank of Baroda
Non-fund-based - LT/ STBG/LCBank of India
Non-fund-based - LT/ STBG/LCCanara Bank
Non-fund-based - LT/ STBG/LCCentral Bank of India
Non-fund-based - LT/ STBG/LCDCB Bank Ltd.
Non-fund-based - LT/ STBG/LCDena Bank
Non-fund-based - LT/ STBG/LCExport Import Bank of India

Credit assessment Β· Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) Β· Standalone accounts Β· FY 2025-26

Indicative long-termβ€”
Indicative short-termβ€”
Scoreβ€”
LiquidityAdequate
DirectionStable
CARE rating Β· Nov 2025DMatches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultIn default (CARE D)
Issuer cooperationNot cooperating since 02 Dec 2021 (58 months) – investment grade cannot be retained
Credit enhancementNone – standalone rating
Next action stable or better (model)26%
Information on file78% Β· missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 26% (Downgrade likely) Β· ML model on 4072 rating histories, AUC 0.666
Rated limitsβ‚Ή11,070 Cr
Not yet allocatedβ€”
Extra debt within 2.5Γ— EBITDAβ€”
Interest coverage0.94Γ—
Limit utilisationβ€”
Open bank charges0 Β· β€”
  • Credit outlook model: 26% chance the next rating action is stable or better
  • Current rating D (below investment grade)
  • Interest coverage 0.94Γ—
  • Issuer not cooperating with the rating agency

Rated limits by facility

Timeline

14 Nov 2025 CARE non-cooperating: DRated limits β‚Ή11,070.4 cr CARE rationale
19 Nov 2024 CARE non-cooperating: DRated limits β‚Ή11,070.4 cr CARE rationale
23 Nov 2023 CARE non-cooperating: DRated limits β‚Ή11,070.4 cr CARE rationale
28 Nov 2022 CARE non-cooperating: DRated limits β‚Ή22,140.8 cr CARE rationale
02 Dec 2021 CARE non-cooperating: DRated limits β‚Ή495 cr CARE rationale
02 Dec 2021 Cash & liquid funds β‚Ή572 cr
From the report

The company incurred cash loss of Rs.572 crore in FY21 vis-Γ -vis debt repayment obligation of Rs.305.38 crore in FY21.

CARE rationale
02 Dec 2021 Debt repayments due in FY21: β‚Ή305.38 cr
From the report

The company incurred cash loss of Rs.572 crore in FY21 vis-Γ -vis debt repayment obligation of Rs.305.38 crore in FY21.

CARE rationale
02 Dec 2021 Debt repayments due in FY22: β‚Ή520.34 cr
From the report

The company has a scheduled debt repayment obligation of Rs.520.34 crore in FY22.

CARE rationale
10 Dec 2020 CARE reaffirmed: DRated limits β‚Ή10,575.4 cr CARE rationale
10 Dec 2020 Cash & liquid funds β‚Ή346 cr
From the report

The company incurred cash loss of Rs.346 crore in FY20 vis -Γ -vis debt repayment obligation of Rs.175.46 crore in FY20.

CARE rationale
10 Dec 2020 Debt repayments due in FY20: β‚Ή175.46 cr
From the report

The company incurred cash loss of Rs.346 crore in FY20 vis -Γ -vis debt repayment obligation of Rs.175.46 crore in FY20.

CARE rationale
10 Dec 2020 Debt repayments due in FY21: β‚Ή305.38 cr
From the report

The company has a scheduled debt repayment obligation of Rs.305.38 crore in FY21. 1Complete definitions of the ratings assigned are available at www.careratings.com and in other CARE publications. 1 CARE Ratings Limited Press Release Analytical approach: Standalone Applicable Criteria Criteria on assigning β€˜outlook’ and β€˜credit watch’ to Credit Ratings CARE’s Policy on Default Recognition Criteria for Short Term Instruments Financial ratios – Non-Financial Sector Liquidity Analysis of Non-Financial Sector Entities Rating Methodology – Construction Sector CARE’s policy on Curing Period About th

CARE rationale
11 Dec 2019 CARE revised: D (Negative)Rated limits β‚Ή10,500 cr CARE rationale
25 Nov 2019 CARE revised: BB+ (Negative)Rated limits β‚Ή10,500 cr CARE rationale
25 Nov 2019 β‚Ή125 cr raised through equity from promoters
From the report

Outlook: Negative) five crore only) Details of facilities/Instruments in Annexure Detailed Rationale and Key Rating Drivers The revision in the ratings assigned to Simplex Infrastructures Limited (Simplex) takes into account non infusion of equity of Rs.125 cr by promoters within the timelines as expected due to lapse of timelines for conversion of share warrants, moderation in profitability in Q2FY20 (refers to the period July 1 to September 30), continued elongation in already high collection period in Q2FY20 with increase in unbilled revenue leading to deterioration of working capital cycle

CARE rationale
25 Nov 2019 β‚Ή746 cr raised
From the report

Besides, Simplex has issued corporate guarantee amounting to ~Rs.746 cr to its group entities.

CARE rationale
25 Nov 2019 β‚Ή25 cr raised
From the report

In January 2019, promoters have further infused Rs.25 crore against the conversion of share warrant and the balance of Rs.125 crore was expected to be infused by November 15, 2019.

CARE rationale
25 Nov 2019 β‚Ή75 cr raised
From the report

However as stated by the management the time period for conversion of balance amount of Rs.125 crore has lapsed and the same will not be infused and the upfront infusion of Rs.75 crore already done will be forfeited.

CARE rationale
25 Nov 2019 Cash & liquid funds β‚Ή107.89 cr
From the report

Further debt repayment obligation in FY20 stands at Rs. 178.46 crore (out of which ~Rs.66 crore already repaid till Sept 30, 2019 including put option of Rs.30 crore exercised) which is expected to be met out of cash accruals (GCA of Rs.107.89 crore during April 1, 2019 to September 30, 2019).

CARE rationale
25 Nov 2019 Average working-capital utilisation 96%
From the report

Average fund based utilization is high at ~96% for 12 month ended Sept. 2019 on account of high receivables.

CARE rationale
14 Aug 2019 CARE revised: BBB (Negative)Rated limits β‚Ή10,500 cr CARE rationale
14 Aug 2019 β‚Ή125 cr raised through equity
From the report

The ratings also factor in company’s pla n to monetize one of the SPVs by the end of March 2020 and equity infusion of Rs.125 cr in respect of balance share warrant proceeds by Nov 2019 which would most be utilized for reduction in debt levels.

CARE rationale
14 Aug 2019 β‚Ή477 cr raised through equity
From the report

Further there was an equity infusion of Rs.477 crore in FY19 which has resulted in marginal reduction in debt resulting in improvement in overall gearing albeit the debt level continues to remain higher than envisaged.

CARE rationale
14 Aug 2019 β‚Ή746 cr raised
From the report

Besides, Simplex has issued corporate guarantee amounting to ~Rs.746 cr to its group entities.

CARE rationale
14 Aug 2019 Average working-capital utilisation 94%
From the report

Average fund based utilization is high at ~94% on account of high receivables.

CARE rationale
10 Jun 2019 CARE revised: A- (Negative)Rated limits β‚Ή10,524.4 cr CARE rationale
10 Jun 2019 β‚Ή452 cr raised through equity
From the report

Further there was an equity infusion of Rs.452 crore in Q1FY19 and Rs.25 crore in Q4FY19 which has resulted in marginal reduction in debt resulting in improvement in overall gearing though the debt continues to remain higher than envisaged.

CARE rationale
10 Jun 2019 β‚Ή477 cr raised through equity
From the report

Overall gearing (including mobilisation advances) improved to 2.27x as on March 31, 2019 as against 3.15x as on March 31, 2018 mainly on account of equity infusion of Rs.477 crore.

CARE rationale
10 Jun 2019 Average working-capital utilisation 93%
From the report

Liquidity The average fund based utilisation for the 12 month period ended April 30, 2019 was ~93% and it continued to remain high on account of slow pace of recovery from debtors.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeSIMPLEX HOUSE 27 SHAKESPEARE SARANI, KOLKATA, IN-WB, 700017
GSTINβ€”
Emailβ€”
Websiteβ€”
Members / shareholdersβ€”

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Simplex Infrastructures Limited

Competitors10identified
Locations6most in Maharashtra

Top competitors by location

CompanyDescriptionDomainFoundedLocation
RELIANCE INFRASTRUCTURE LIMITED Real Estate & Infrastructure Β· Community, personal and Social Services rinfra.com 2002 Mumbai, Maharashtra, India
LODHA DEVELOPERS LIMITED Β· Construction β€” β€” Mumbai, Maharashtra, India
IRCON INTERNATIONAL LIMITED Real Estate & Infrastructure Β· Real Estate & Construction ircon.org β€” New Delhi, Delhi, India
DILIP BUILDCON LIMITED Β· Construction β€” β€” Bhopal, Madhya Pradesh, India
G R INFRAPROJECTS LIMITED Β· Construction β€” β€” Ahmedabad, Gujarat, India
DLF Limited Real Estate & Infrastructure Β· Real Estate & Construction dlf.in 1946 Gurgaon, India
GMR POWER AND URBAN INFRA LIMITED Part of GMR Group. gmrpui.com β€” Gurgaon, Haryana, India
KIRLOSKAR INDUSTRIES LIMITED Β· Real Estate and Renting β€” β€” Pune, Maharashtra, India
Astral Plastic Pipes & Water Tanks Β· Cement, Building Materials & Polymers astralltd.com β€” Ahmedabad, India
EMBASSY DEVELOPMENTS LIMITED Β· Construction β€” β€” Gurgaon, Haryana, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.